2019 National Cancer Institute Director’s Award: Clinical Oncology Research Enterprise
Westat will receive the National Cancer Institute’s (NCI’s) Director's Award for Clinical Science on December 5, 2019. The honor spotlights Westat researchers’ work with developing and implementing an enterprise-level information technology (IT) platform called the Cancer Therapy Evaluation Program’s (CTEP’s) Clinical Oncology Research Enterprise (CORE). NCI notes Westat’s work as “outstanding leadership in the development and implementation of the CTEP CORE.”
The award is for the Cancer Trials Support Unit (CTSU) team’s contributions to developing the CORE, a suite of applications developed to support CTEP’s mission to improve the lives of cancer patients by finding better ways to treat, control, and cure cancer. The team includes NCI staff, and Amandeep Singh and Ravi Rajaram from Westat.
CTEP CORE represents a unified, comprehensive, and innovative IT solution that fully supports CTEP processes. It is an integrated collection of 40+ clinical trial research management applications that assist CTEP, other NCI staff, and the extramural community in many clinical trial domains, such as study administration and logistics, clinical data capture and reporting, correlative study data, regulatory monitoring and reporting, and data quality and control. Westat’s CTSU team has developed several of these applications and also worked with various CTEP contractors to integrate the systems to provide a seamless and efficient clinical site user experience.
Learn more about Westat and how we are helping NCI’s CTSU.